Cardiovascular toxicity of Bruton tyrosine kinase inhibitors: forget about selectivity but watch the clock ow.ly/XlhQ50SIOCg #clinicatrialsandobservations #lymphoidneoplasia

This #JACCCardioOnc study demonstrates that genomic analysis, coupled with human induced pluripotent #stemcell modeling, is an efficient platform for assessing the mechanisms of doxorubicin-induced #cardiotoxicity. bit.ly/3UeNFL8 #CardioOnc

Excited to announce our latest #CardioOncology research: "HFA-ICOS score predicts anthracycline-related CV toxicity and all-cause mortality". Congratulations to the CardioTox team! academic.oup.com/eurheartj/adva… EHJ Editor-in-Chief CardioQuironMadrid International Cardio-Oncology Society Borja Rivero Santana Jesús Saldaña García Cardiología La Paz

Anthracycline-induced cardiovascular toxicity: validation of the Heart Failure Association and International Cardio-Oncology Society risk score just published in EHJ. doi.org/10.1093/eurhea… #Anthracycline #heart European Society of Cardiology Journals European Society of Cardiology

Proud 2 present this vision for #CardioOnc in Circulation as part of American Heart Association centennial collection! Cardio-Oncology: A New Clinical Frontier and Novel Platform for Cardiovascular Investigation | Circulation ahajournals.org/doi/10.1161/CI…

Anthracycline Cardiotoxicity Induces Progressive Changes in Myocardial Metabolism and Mitochondrial Quality Control: Novel Therapeutic Target Cardiac atrophy, global hypometabolism, early transient-enhanced mitophagy, candidate targets AIC prevention. jacc.org/doi/10.1016/j.…

Have a look !!! 👀👀💣💣

Anthracycline-induced cardiovascular toxicity: validation of the Heart Failure Association and International Cardio-Oncology Society risk score. #EHJ academic.oup.com/eurheartj/adva… #anthracycline #CVD #toxicity #HF European Society of Cardiology Journals European Society of Cardiology

An unmissable opportunity to learn from the powerhouse that is Dr Ky! #cardioonc

📌The right heart in 👥 with #cancer. A scientific 📝 of the #HFA of the @ESCardio & the ESC Council of #CardioOncology #PositionPaper #RV #EHJHF

👉 Delighted to share our study evaluating the added value of scar quantification for arrhythmic risk prediction in non-ischaemic cardiomyopathy JACC Journals European Society of Cardiology European Society of Cardiology News doi.org/10.1016/j.jacc…

SAVE THE DATE!! If interested in #CardioOnc, don’t miss the European Society of Cardiology Cardio-Oncology summit 2025 📅 20-21 June 2025 📍 Florence, Italy 🇮🇹 #ESCCongress #ESCCongress2024

Key messages from the first joint #ESC #ESMO session on #CardioOncology at #ESCCongress2024. Come back to watch the session again: esc365.escardio.org/esc-congress/s…

Strain surveillance during #chemotherapy to improve cardiovascular outcomes: the SUCCOUR-MRI trial released at #ESCCongress and just published in #EHJ👉 bit.ly/4gmbmKj EHJ Editor-in-Chief

Rationale and design of RESILIENCE: A prospective randomized clinical trial evaluating remote ischaemic conditioning for the prevention of anthracycline cardiotoxicity a novel non-invasive intervention to prevent AC in a cohort of high-risk patients onlinelibrary.wiley.com/doi/full/10.10…

📣I have just been elected as member of the Committee for Atrial Disorders of the Heart Failure Association of the European Society of Cardiology 2024/2026! Thanks to the nominating committee for giving me this possibility 🫀Wilfried Mullens Matteo Cameli, MD, PhD Antonio Cannata'

📚 Huge differences in CardioOncology practice and imaging use in Italy🇮🇹🇮🇹Read our latest publication from ANMCO and SIECVI🩺👨🏻‍⚕️👩🏻‍⚕️